Moon Surgical Enhances Leadership with Chris Toth on Board for Future Growth

Moon Surgical Appoints Chris Toth as Independent Board Member

In a significant move aimed at elevating its commercial trajectory, Moon Surgical, a frontrunner in laparoscopic surgical technology, has appointed Chris Toth as an independent member of its Board of Directors. With over 20 years of experience in leading commercial operations, Toth's presence on the board marks a crucial step for the company as it prepares to market its innovative Maestro System.

Chris Toth, who is currently the Executive Vice President and Group President of Baxter International's Kidney Care segment, is poised to leverage his vast expertise to help Moon Surgical in its commercial expansion. As he transitions to the role of CEO of Vantive — the name slated for Baxter's Kidney Care segment upon its sale — Toth's extensive background, including his previous experience as CEO of Varian, will provide invaluable insights into scaling healthcare solutions that merge equipment with services.

Anne Osdoit, the CEO of Moon Surgical and a Partner at Sofinnova Partners, expressed enthusiasm regarding Toth's appointment, emphasizing the transformational impact it will potentially have. “Chris brings unparalleled expertise in scaling commercial operations globally. His operational insights and visionary leadership will be critical as we commercially launch the Maestro System and promote its use among surgical teams worldwide,” she stated.

The Maestro System is set to revolutionize soft tissue surgeries, addressing a pressing need for efficiency in both small operating rooms and outpatient settings. With the ability to support high-volume procedures while ensuring operational consistency and surgeon control, the Maestro System is uniquely positioned to impact approximately 20 million soft tissue operations performed globally each year.

Toth's experience in guiding impactful healthcare initiatives will be essential for Moon Surgical as it strives to encourage widespread adoption of the Maestro System, thereby ensuring long-term sustainability and growth. Toth himself commented on his new role, stating, “I am confident in Moon Surgical's differentiated value and business model. I'm honored to join the board and support their mission to transform the operating room with the Maestro System.”

Founded in 2020 and operating out of Paris and San Francisco, Moon Surgical is dedicated to creating the future of operating rooms—efficient, sustainable, and digitalized. The combination of the Maestro System with the intelligent insights it provides empowers healthcare professionals to make informed decisions, ultimately enhancing patient care.

As Moon Surgical embarks on this new chapter with Chris Toth guiding its commercial strategies, it aims to inspire innovation in surgical practices and reinforce its commitment to improving surgical care globally. For further information about their advancements and vision, you can visit their official website at www.moonsurgical.com or follow them on LinkedIn.

The integration of Toth's leadership with Moon Surgical's innovative approach signals a promising horizon for laparoscopic surgical solutions, and medical professionals are closely watching how this partnership will redefine surgical practices.

Conclusion

With Chris Toth on board, Moon Surgical is poised not only to accelerate the commercial success of the Maestro System but also to contribute significantly to the evolution of surgical environments, driving improvements in efficiency and patient outcomes. This strategic appointment reflects the company's commitment to advancing healthcare technology and maintaining a dynamic, inclusive corporate culture that fosters creativity and collaboration among its team members.